Blueprint Medicines Corporation (BPMC) has a market capitalization of $8.36B and trades at $129.46. The 52-week range is 73.04-129.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -121, Earnings Per Share (EPS) of $-1.07, annual revenue of $508.82M.
The stock has a beta of 0.83, operates in the Healthcare sector.
